Literature DB >> 18577812

Effects of increasing particle size of low-density lipoprotein on restenosis after coronary stent implantation.

Jung-Sun Kim1, Myung-Hyun Kim, Byoung Kwon Lee, Se-Joong Rim, Pil-Ki Min, Se-Jung Yoon, Jeong-Ho Kim, Ji-Hyuck Rhee, Young Won Yoon, Bum Kee Hong, Hyuck Moon Kwon, Changsoo Kim.   

Abstract

BACKGROUND: Small dense low-density lipoprotein (LDL) has emerged as an important risk factor in coronary atherosclerosis and vascular inflammation, which is related to neointimal hyperplasia. Therefore, the aim of the present study was to investigate whether changes in LDL particle size are related to in-stent restenosis (ISR). METHODS AND
RESULTS: The LDL subfraction and lipid profiles were measured in 274 patients (412 stents) at both baseline and follow-up coronary angiography (CAG). The incidence of ISR (80 lesions, 19.4%) was lower in the patients with increased LDL particle size than in those with no change or decrease (14.2% vs 25.8%, p=0.004). Logistic multivariate analysis revealed that stent length (>or=24 mm) (odds ratio (OR) =1.913, p=0.027), post minimal luminal diameter (>3 mm) (OR =0.528, p=0.028), acute coronary syndrome (OR =2.294, p=0.005), decrease in high-density lipoprotein-cholesterol (OR =1.028, p=0.047) and increase in LDL particle size (OR =0.528, p=0.031) were independent predictors for ISR.
CONCLUSIONS: In the present study, an increase in the LDL particle size between baseline and follow-up CAG was associated with reduced incidence of ISR. Therefore, modification of LDL particle size may have a beneficial effect on the risk of ISR.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18577812     DOI: 10.1253/circj.72.1059

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  6 in total

1.  Small dense low density lipoprotein particles are associated with poor outcome after angioplasty in peripheral artery disease.

Authors:  Vincenzo Jacomella; Philipp A Gerber; Kathrin Mosimann; Marc Husmann; Christoph Thalhammer; Ian Wilkinson; Kaspar Berneis; Beatrice R Amann-Vesti
Journal:  PLoS One       Date:  2014-09-29       Impact factor: 3.240

2.  Diagnostic value of microRNA-143 in predicting in-stent restenosis for patients with lower extremity arterial occlusive disease.

Authors:  Zhi-Hai Yu; Hai-Tao Wang; Can Tu
Journal:  Eur J Med Res       Date:  2017-01-05       Impact factor: 2.175

Review 3.  Small Dense LDL: Scientific Background, Clinical Relevance, and Recent Evidence Still a Risk Even with 'Normal' LDL-C Levels.

Authors:  Harold Superko; Brenda Garrett
Journal:  Biomedicines       Date:  2022-04-01

4.  Atherogenic Index of Plasma and the Risk of In-Stent Restenosis in Patients with Acute Coronary Syndrome beyond the Traditional Risk Factors.

Authors:  Yong Zhu; Maolin Chen; Kesen Liu; Ang Gao; Xiangyun Kong; Yan Liu; Hongya Han; Hong Li; Huagang Zhu; Jianwei Zhang; Yingxin Zhao
Journal:  J Atheroscler Thromb       Date:  2021-09-09       Impact factor: 4.394

5.  Cholesterol forms and traditional lipid profile for projection of atherogenic dyslipidemia: lipoprotein subfractions and erythrocyte membrane cholesterol.

Authors:  Hüseyin Avni Uydu; Mehmet Bostan; Mehtap Atak; Adnan Yılmaz; Adem Demir; Buket Akçan; Fatih Sümer; Nimet Baltaş; Zakir Karadağ; Yavuz Uğurlu; Asım Orem
Journal:  J Membr Biol       Date:  2013-11-16       Impact factor: 1.843

6.  Incidence and risk factors of in-stent restenosis after percutaneous coronary intervention in patients from southern China.

Authors:  Mingrui Li; Jingyuan Hou; Xiaodong Gu; Ruiqiang Weng; Zhixiong Zhong; Sudong Liu
Journal:  Eur J Med Res       Date:  2022-01-22       Impact factor: 2.175

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.